Spectral analysis of the DNA targeting bisalkylaminoanthraquinone DRAQ5 in intact living cells

Cytometry Part A

Volumn 69, Issue 8, 2006, Pages 805-814

  Njoh, Kerenza L ^a   Patterson, Laurence H ^b   Zloh, Mire ^c   Wiltshire, Marie ^a   Fisher, Janet ^a   Chappell, Sally ^a   Ameer Beg, Simon ^d   Bai, Yanhong ^d   Matthews, Daniel ^a   Errington, Rachel J ^a   Smith, Paul J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

^c UNIVERSITY OF LONDON   (United Kingdom)

^d MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Cell cycle; DNA binding; DRAQ5; EGFP cyclin B1; Spectral imaging

Indexed keywords

ANTHRAQUINONE DERIVATIVE; CYCLIN B1; DYE; ENHANCED GREEN FLUORESCENT PROTEIN; HOE 33342;

ARTICLE; BASE PAIRING; BINDING AFFINITY; CELL AGING; CELL CYCLE; CONFOCAL LASER MICROSCOPY; DNA BINDING; FLOW CYTOMETRY; FLUORESCENCE; GENE TARGETING; HUMAN; HUMAN CELL; MOLECULAR IMAGING; MOLECULAR MODEL; PRIORITY JOURNAL; SIGNAL NOISE RATIO; SPECTROSCOPY;

BENZIMIDAZOLES; BONE NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CYCLIN B; DNA, NEOPLASM; DNA-BINDING PROTEINS; FLOW CYTOMETRY; FLUORESCENT DYES; HUMANS; IMAGE CYTOMETRY; LIGANDS; MICROSCOPY, CONFOCAL; NITROGEN OXIDES; OSTEOSARCOMA; SPECTROMETRY, FLUORESCENCE; SPECTRUM ANALYSIS;

EID: 33749146554     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.20308     Document Type: Article

References (35)

1. Matthews DR, Summers HD, Njoh K, Errington RJ, Smith PJ, Ameer-Beg S, Vojnovic B. Time-resolved fluorescence measurements using self-pulsing 650-nm laser diodes. Proc SPIE 2005;5705:23-31.
2. Smith PJ, Blunt NJ, Desnoyers R, Giles Y, Patterson LH. DNA topoisomerase II-dependent cytotoxicity of alkylaminoanthraquinones and their N-oxides. Cancer Chemother Pharmacol 1997;39:455-461.
3. Larson ED, Drummond JT. Human mismatch repair and G*T mismatch binding by hMutSα in vitro is inhibited by adriamycin, actinomycin D, and nogalamycin. J Biol Chem 2001;276:9775-9783.
4. Evans ND, Errington RJ, Shelley M, Feeney GP, Chapman MJ, Godfrey KR, Smith PJ, Chappell MJ. A mathematical model for the in vitro kinetics of the anti-cancer agent topotecan. Math Biosci 2004;189:185-217.
5. Smith PJ, Blunt N, Wiltshire M, Hoy T, Teesdale-Spittle P, Craven MR, Watson JV, Amos WB, Errington RJ, Patterson LH. Characteristics of a novel deep red/infrared fluorescent cell-permeant DNA probe, DRAQ5, in intact human cells analyzed by flow cytometry, confocal and multiphoton microscopy. Cytometry 2000;40:280-291.
6. Smith PJ, Wiltshire M, Davies S, Patterson LH, Hoy T. A novel cell permeant and far red-fluorescing DNA probe, DRAQ5, for blood cell discrimination by flow cytometry. J Immunol Methods 1999;229:131-139.
7. Eriksson M, Norden B, Eriksson S. Anthracycline-DNA interactions studied with linear dichroism and fluorescence spectroscopy. Biochemistry 1988;27:8144-8151.
8. Koch TS, Rava RP. Interpreting the visible absorption bands of 1,4-(dihydroxy)-9,10-anthraquinone and its metal chelates. Biophys Chem 1990;36:187-199.
9. Islam SA, Neidle S, Gandecha BM, Partridge M, Patterson LH, Brown JR. Comparative computer graphics and solution studies of the DNA interaction of substituted anthraquinones based on doxorubicin and mitoxantrone. J Med Chem 1985;28:857-864.
10. Bell DH. Characterization of the fluorescence of the antitumor agent, mitoxantrone. Biochim Biophys Acta 1988;949:132-137.
11. Adhikary A, Buschmann V, Muller C, Sauer M. Ensemble and single-molecule fluorescence spectroscopic study of the binding modes of the bis-benzimidazole derivative Hoechst 33258 with DNA. Nucleic Acids Res 2003;31:2178-2186.
12. Lakowicz JR. Principles of Fluorescence Spectroscopy, 2nd ed. New York: Plenum; 2003.
13. Smith PJ, Nakeff A, Watson JV. Flow-cytometric detection of changes in the fluorescence emission spectrum of a vital DNA-specific dye in human tumour cells. Exp Cell Res 1985;159:37-46.
14. Watson JV, Nakeff A, Chambers SH, Smith PJ. Flow cytometric fluorescence emission spectrum analysis of Hoechst-33342-stained DNA in chicken thymocytes. Cytometry 1985;6:310-315.
15. Loontiens FG, Regenfuss P, Zechel A, Dumortier L, Clegg RM. Binding characteristics of Hoechst 33258 with calf thymus DNA, poly[d(A-T)], and d(CCGGAATTCCGG): Multiple stoichiometries and determination of tight binding with a wide spectrum of site affinities. Biochemistry 1990;29:9029-9039.
16. Thomas N, Goodyer ID. Stealth sensors: Real-time monitoring of the cell cycle. Targets 2003;2:26-33.
17. Watson JV, Chambers SH, Smith PJ. A pragmatic approach to the analysis of flow cytometric DNA histogram data. Cytometry 1987;8:1-8.
18. Schmidt MW, Baldridge KK, Boatz JA, Elbert ST, Gordon MS, Jensen JA, Koseki S, Matsunaga KA, Nguyen KA, Su S, Windus TL. The general atomic and molecular electronic structure system. J Comp Chem 1993;14:1347.
19. Katchalski-Katzir E, Shariv I, Eisenstein M, Friesem AA, Aflalo C, Vakser IA. Molecular surface recognition: Determination of geometric fit between proteins and their ligands by correlation techniques. Proc Natl Acad Sci USA 1992;89:2195-2199.
20. Vakser IA. Long-distance potentials: An approach to the multiple-minima problem in ligand-receptor interaction. Protein Eng 1996; 9:37-41.
21. Mohamadi F, Richards NGJ, Guida WC, liskamp R, Lipton M, Caufield C, Chang G, Hendrickson T, Still WC. MacroModel - An integrated software system for modeling organic and bioorganic molecules using molecular mechanics. J Comp Chem 1990;11:440-467.
22. Lerner JM, Zucker RM. Calibration and validation of confocal spectral imaging systems. Cytometry A 2004;62:8-34.
23. Zucker RM, Lerner JM. Wavelength and alignment tests for confocal spectral imaging systems. Microsc Res Tech 2005;68:307-319.
24. Cheng CC, Zbinden G, Zee-Cheng RK. Comparison of antineoplastic activity of aminoethylaminoanthraquinones and anthracycline antibiotics. J Pharm Sci 1979;68:393-396.
25. Fox ME, Smith PJ. Subcellular localisation of the antitumour drug mitoxantrone and the induction of DNA damage in resistant and sensitive human colon carcinoma cells. Cancer Chemother Pharmacol 1995;35:403-410.
26. Smith PJ, Desnoyers R, Blunt N, Giles Y, Patterson LH, Watson JV. Flow cytometric analysis and confocal imaging of anticancer alkylaminoanthraquinones and their N-oxides in intact human cells using 647-nm krypton laser excitation. Cytometry 1997;27:43-53.
27. Smith PJ, Sykes HR, Fox ME, Furlong IJ. Subcellular distribution of the anticancer drug mitoxantrone in human and drug-resistant murine cells analyzed by flow cytometry and confocal microscopy and its relationship to the induction of DNA damage. Cancer Res 1992;52:4000-4008.
28. Marquez N, Chappell SC, Sansom OJ, Clarke AR, Teesdale-Spittle P, Errington RJ, Smith PJ. Microtubule stress modifies intra-nuclear location of Msh2 in mouse embryonic fibroblasts. Cell Cycle 2004;3:662-671.
29. Schnedl W, Dann O, Schweizer D. Effects of counterstaining with DNA binding drugs on fluorescent banding patterns of human and mammalian chromosomes. Eur J Cell Biol 1980;20:290-296.
30. Cosa G, Focsaneau KS, McLean JR, McNamee JP, Scaiano JC. Photophysical properties of fluorescent DNA-dyes bound to single- and double-stranded DNA in aqueous buffered solution. Photochem Photobiol 2001;73:585-599.
31. Fan JY, Valu KK, Woodgate PD, Baguley BC, Denny WA. Aniline mustard analogues of the DNA-intercalating agent amsacrine: DNA interaction and biological activity. Anticancer Drug Des 1997;12:181-203.
32. Bigioni M, Salvatore C, Palma C, Manzini S, Animati F, Lombardi P, Pratesi G, Supino R, Zunino F. Cytotoxic and antitumor activity of MEN 10710, a novel alkylating derivative of distamycin. Anticancer Drugs 1997;8:845-852.
33. Shenkenberg TD, Von Hoff DD. Mitoxantrone: A new anticancer drug with significant clinical activity. Ann Intern Med 1986;105:67-81.
34. Errington RJ, Ameer-Beg SM, Vojnovic B, Patterson LH, Zloh M, Smith PJ. Advanced microscopy solutions for monitoring the kinetics and dynamics of drug-DNA targeting in living cells. Adv Drug Deliv Rev 2005;57:153-167.
35. van Zandvoort MA, de Grauw CJ, Gerritsen HC, Broers JL, oude Egbrink MG, Ramaekers FC, Slaaf DW. Discrimination of DNA and RNA in cells by a vital fluorescent probe: Lifetime imaging of SYTO13 in healthy and apoptotic cells. Cytometry 2002;47:226-235.